Cargando…

Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?

Periprosthetic joint infections (PJI) of the hip and the knee are grossly classified as early post-operative, acute hematogenous and late chronic infections. Whereas two-stage exchange arthroplasty is the standard of care in North America for treating chronic infections, irrigation and debridement (...

Descripción completa

Detalles Bibliográficos
Autores principales: Triantafyllopoulos, Georgios K, Soranoglou, Vasileios, Memtsoudis, Stavros G, Poultsides, Lazaros A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027009/
https://www.ncbi.nlm.nih.gov/pubmed/27672567
http://dx.doi.org/10.5312/wjo.v7.i9.546
_version_ 1782454168532811776
author Triantafyllopoulos, Georgios K
Soranoglou, Vasileios
Memtsoudis, Stavros G
Poultsides, Lazaros A
author_facet Triantafyllopoulos, Georgios K
Soranoglou, Vasileios
Memtsoudis, Stavros G
Poultsides, Lazaros A
author_sort Triantafyllopoulos, Georgios K
collection PubMed
description Periprosthetic joint infections (PJI) of the hip and the knee are grossly classified as early post-operative, acute hematogenous and late chronic infections. Whereas two-stage exchange arthroplasty is the standard of care in North America for treating chronic infections, irrigation and debridement (I and D) with retention of implants has been used in an attempt to treat the other two types of PJIs. The rationale of this approach is that a PJI may be eradicated without the need of explanting the prostheses, as long as it has not transitioned into a chronic state. With the present paper, we review current evidence regarding the role of I and D with implant retention for treating PJIs of the hip and the knee. While a very wide range of success rates is reported in different studies, a short period of time between initiation of symptoms and intervention seems to play a prominent role with regards to a successful outcome. Moreover, pathogens of higher virulence and resistance to antibiotics are associated with a poorer result. Specific comorbidities have been also correlated with a less favorable outcome. Finally, one should proceed with serial I and Ds only under the condition that a predefined, aggressive protocol is applied. In conclusion, when treating a PJI of the hip or the knee, all the above factors should be considered in order to decide whether the patient is likely to benefit from this approach.
format Online
Article
Text
id pubmed-5027009
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-50270092016-09-26 Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how? Triantafyllopoulos, Georgios K Soranoglou, Vasileios Memtsoudis, Stavros G Poultsides, Lazaros A World J Orthop Minireviews Periprosthetic joint infections (PJI) of the hip and the knee are grossly classified as early post-operative, acute hematogenous and late chronic infections. Whereas two-stage exchange arthroplasty is the standard of care in North America for treating chronic infections, irrigation and debridement (I and D) with retention of implants has been used in an attempt to treat the other two types of PJIs. The rationale of this approach is that a PJI may be eradicated without the need of explanting the prostheses, as long as it has not transitioned into a chronic state. With the present paper, we review current evidence regarding the role of I and D with implant retention for treating PJIs of the hip and the knee. While a very wide range of success rates is reported in different studies, a short period of time between initiation of symptoms and intervention seems to play a prominent role with regards to a successful outcome. Moreover, pathogens of higher virulence and resistance to antibiotics are associated with a poorer result. Specific comorbidities have been also correlated with a less favorable outcome. Finally, one should proceed with serial I and Ds only under the condition that a predefined, aggressive protocol is applied. In conclusion, when treating a PJI of the hip or the knee, all the above factors should be considered in order to decide whether the patient is likely to benefit from this approach. Baishideng Publishing Group Inc 2016-09-18 /pmc/articles/PMC5027009/ /pubmed/27672567 http://dx.doi.org/10.5312/wjo.v7.i9.546 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Triantafyllopoulos, Georgios K
Soranoglou, Vasileios
Memtsoudis, Stavros G
Poultsides, Lazaros A
Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
title Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
title_full Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
title_fullStr Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
title_full_unstemmed Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
title_short Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
title_sort implant retention after acute and hematogenous periprosthetic hip and knee infections: whom, when and how?
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027009/
https://www.ncbi.nlm.nih.gov/pubmed/27672567
http://dx.doi.org/10.5312/wjo.v7.i9.546
work_keys_str_mv AT triantafyllopoulosgeorgiosk implantretentionafteracuteandhematogenousperiprosthetichipandkneeinfectionswhomwhenandhow
AT soranoglouvasileios implantretentionafteracuteandhematogenousperiprosthetichipandkneeinfectionswhomwhenandhow
AT memtsoudisstavrosg implantretentionafteracuteandhematogenousperiprosthetichipandkneeinfectionswhomwhenandhow
AT poultsideslazarosa implantretentionafteracuteandhematogenousperiprosthetichipandkneeinfectionswhomwhenandhow